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Introduction
This overview provides a summary of many aspects of solid
organ transplantation in the United States, and is produced
as part of the 2005 OPTN/SRTR Annual Report. The Annual
Report is prepared by the Scientific Registry of Transplant
Recipients (SRTR) in collaboration with the Organ Procure-
ment and Transplantation Network (OPTN) under contract
with the Health Resources and Services Administration
(HRSA). The Annual Report is intended to provide valuable
information to patients, the transplant community, the pub-
lic, and the Federal Government by publishing a vast array
of knowledge on activities related to solid organ transplan-
tation.
Ten groups of authors, all experts in various areas of trans-
plantation, have produced the 10 detailed articles in this
report. Each article provides an in-depth look at the cur-
rent state of specific aspects of transplantation, as well as
trends over the last decade. The text and figures in these
articles contain some new analyses but are based mainly
Note on sources: The articles in this report are based on the refer-
ence tables in the 2005 OPTN/SRTR Annual Report, which are not
included in this publication. Many relevant data appear in the tables
included here; other tables from the Annual Report that serve as
the basis for this article include the following: Tables 1.1, 1.2, 1.3,
1.7, 1.13, 2.1, 2.8, 5.1a, 5.2, 5.4, 5.11a–c, 5.14, 6.4, 7.4, 8.7, 8.11,
8.12, 8.13, 11.1a, 11.3, 11.5, 12.2, 13.1a, 13.4 and 13.12. All of
these tables may be found online at http://www.ustransplant.org.
on the wealth of information in the reference tables of the
Annual Report, which have been prepared by the Univer-
sity Renal Research and Education Association (URREA),
the contractor for the SRTR since October 2000. These
10 articles and reference tables are included in the Annual
Report and may be found online at www.ustransplant.org
and www.optn.org.
Summary Statistics on Organ
Transplantation in the United States
for 2003–2004
There were over 14 000 organ donors in the United States
in 2004, an increase of 695 donors (7%) over 2003. During
this time the number of living donors increased by 3% to
7002, while the number of deceased donors grew by 11%
to 7152, the largest annual increase in deceased donors in
the last 10 years. This increase in donors led to an additional
2240 deceased donor organs recovered for transplantation
from the previous year, an increase of 10% (Table 1). Some
of this increase can likely be attributed to efforts that fo-
cus on increasing the supply of organs for transplantation,
such as the Organ Donation Breakthrough Collaborative,
which started in the fall of 2003. The trends in organ do-
nation are discussed in detail in an accompanying article,
‘Organ Donation and Utilization 1995–2004: Entering the
Collaborative Era’.
The impact of the increase in the number of organs recov-
ered is evident in the number of transplants performed in
2004. Just over 26 500 organs were transplanted in the
United States during 2004, over 19 500 of them from de-
ceased donors and almost 7000 from living donors. These
numbers represent an increase of 6% in the total num-
ber of organs transplanted, a 3% increase in living donor
transplants and a 7% increase in deceased donor trans-
plants compared to 2003, as shown in Table 2. There were
just over 7300 deaths reported for patients waiting for a
transplant in 2004. This is an increase over the number re-
ported in 2003 (7091). However, since the size of the wait-
ing list also increased during this time, the overall death
rate showed a slight decrease.
Even with the increasing number of transplants being
performed, the demand for transplantation far exceeds
the supply of available organs. The increasing demand
for transplantation is made apparent by the increasing
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Table 1: Growth in number of deceased donor organs recovered,
2003–2004
End of year
Organs 2003 2004 Percent change
Total 22 997 25 237 9.7%
Kidney 11 437 12 575 10.0%
Pancreas 1773 2021 14.0%
Liver 5773 6405 10.9%
Intestine 122 167 36.9%
Heart 2120 2096 −1.1%
Lung 1772 1973 11.3%
Source: 2005 OPTN/SRTR Annual Report, Table 1.2.
Table 2: Growth in number of transplanted organs, 2003–2004
Year
Organs 2003 2004 Percent change
Total 25 083 26 539 5.8%
Deceased donor 18 272 19 549 7.0%
Living donor 6811 6990 2.6%
Kidney 14 856 15 671 5.5%
Deceased donor 8388 9025 7.6%
Living donor 6468 6646 2.8%
PTA 117 132 12.8%
PAK 343 418 21.9%
Kidney-pancreas 868 879 1.3%
Liver 5364 5780 7.8%
Deceased donor 5043 5457 8.2%
Living donor 321 323 0.6%
Intestine 52 52 0.0%
Heart 2026 1961 −3.2%
Lung 1080 1168 8.1%
Deceased donor 1065 1153 8.3%
Living donor 15 15 0.0%
Heart-lung 28 37 32.1%
Source: 2005 OPTN/SRTR Annual Report, Table 1.7. PTA:
Pancreas transplant alone. PAK: Pancreas after kidney.
number of candidates on the waiting list for a deceased
donor organ. As seen in previous years, more patients are
added to the waiting list than are removed due to trans-
plantation, death, or on rare occasion, for recovery from
organ failure. There were over 86 000 patients waiting for
an organ at the end of 2004, over 4000 more than at the
end of 2003 (Table 3). As seen in Table 3, the number of pa-
tients waiting for a kidney, pancreas, or intestine transplant
displayed the largest percent increases for 2004 compared
to 2003; during the same time period, the number of pa-
tients waiting for a liver or a lung increased only slightly
(∼1%), and the number of candidates waiting for a heart
or heart-lung actually decreased by about 7% and 10%, re-
spectively. For the kidney, liver, and lung waiting lists (and
in the total number of candidates awaiting any organ), the
greatest growth has been among those aged 50–64 and
65 and older. Longer time trends and more detailed dis-
cussions of waiting list characteristics can be found in the
three accompanying organ-specific articles of the report.
Table 3: Growth in number of patients on the waiting list, 2003–
2004
End of year
Organs 2003 2004 Percent change
Total 82 259 86 378 5.0%
Kidney 53 840 57 910 7.6%
PTA 454 504 11.0%
PAK 919 973 5.9%
Kidney-pancreas 2370 2403 1.4%
Liver 17 032 17 133 0.6%
Intestine 168 196 16.7%
Heart 3475 3237 −6.8%
Lung 3812 3851 1.0%
Heart-lung 189 171 −9.5%
Source: 2005 OPTN/SRTR Annual Report, Table 1.3. PTA:
Pancreas transplant alone. PAK: Pancreas after kidney.




Deceased donor 94.6% 81.1%
Living donor 97.9% 90.2%
Pancreas alone 96.2% 90.6%
Pancreas after kidney 95.5% 84.4%
Kidney-pancreas 95.3% 85.9%
Liver
Deceased donor 86.8% 73.1%





Source: 2005 OPTN/SRTR Annual Report, Table 1.13.
Key outcomes after transplantation include (1) survival of
the transplant recipients and (2) the function of trans-
planted grafts. Table 4 displays 1- and 5-year unadjusted
patient survival for all transplant recipients by organ, using
the most recent cohort for which adequate follow-up ex-
ists. The cohort used to compute 1-year survival consists
of recipients transplanted in 2002–2003, while the cohort
for 5-year survival is based on the recipients transplanted
in 1998–2003. One-year patient survival rates were highest
for kidney and pancreas recipients, ranging from about 95–
98%; corresponding survival for liver, intestine and heart re-
cipients was approximately 86–88%, about 83% for lung,
and lowest for the small number of heart-lung recipients
with around 58% surviving at 1-year.
Table 5 shows graft survival, the percentage of trans-
planted organs that are still functional 1 and 5 years after
transplantation by type of organ. As with patient survival,
graft survival was calculated based on the most recent co-
hort for which sufficient follow-up was available. Graft sur-
vival rates are lower than the corresponding patient survival
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Deceased donor 89.0% 66.7%
Living donor 95.1% 80.2%
Pancreas alone 76.9% 55.8%
Pancreas after kidney 77.6% 56.7%
Kidney-pancreas (kidney) 91.7% 76.5%
Kidney-pancreas (pancreas) 85.8% 71.0%
Liver
Deceased donor 82.2% 66.9%





Source: 2005 OPTN/SRTR Annual Report, Table 1.13.
rates due to the fact that patients may survive a graft fail-
ure by receiving a second transplant or with an alternative
therapy, such as dialysis for kidney transplant recipients or
insulin therapy for pancreas transplant recipients.
The Articles in the 2005 SRTR Report on the
State of Transplantation
The articles in this report cover a broad range of topics re-
lated to solid organ transplantation in the United States.
Individual articles are devoted to each of the three main
organ areas: kidney and pancreas, liver and intestine, and
heart and lung. There are also articles devoted to organ do-
nation, immunosuppression and pediatric transplantation.
The structure and use of the OPTN/SRTR data are dis-
cussed in an article on analytical approaches and database
design. This article also outlines some of the analytical
methods used by the SRTR and provides some insight
into many of the challenges faced in analyzing the trans-
plant data. In addition, one article is devoted to the analyt-
ical methods behind the SRTR’s regular public reports on
transplant center and OPO performance.
The special article in this year’s report describes the de-
velopment and implementation of a new lung allocation
policy that went into effect on May 4, 2005. A tremendous
amount of effort has been invested into developing the
new allocation policy that distributes organs to candidates
waiting for a lung transplant based on transplant benefit
rather than solely on waiting time.
Summaries and data highlights of each article follow.
Organ donation and utilization
This year’s article is the first to report a full year’s worth of
data on organ donation and usage following initiation of the
Organ Donation Breakthrough Collaborative. The Collabo-
rative effort, which began in September 2003 and contin-
ues today, seeks to save lives and improve outcomes by
challenging organ procurement organizations, transplant
centers and donor hospitals to develop and disseminate
their best practices. As background, the article reviews the
philosophical transition involved in the development of the
donation service area before turning to the Collaborative ef-
fort and its major findings. The article also includes a review
of 10-year trends for deceased donor organs, expanded cri-
teria organs, donation after cardiac death and living dona-
tion. Among the highlights are the following findings:
(i) Of the 552 largest U.S. hospitals targeted by the first
Collaboratives, 184 met and sustained the goal of a
75% conversion rate for a period of 12 months. Partic-
ipating hospitals achieved a 14% increase in the num-
ber of deceased donors, compared with their own per-
formances for the same period the prior year. The in-
crease for hospitals not in the collaborative was 8%,
a substantial jump over previous years that indicated
dissemination of best practices was successful.
(ii) Overall, the trend in organ procurement organiza-
tion (OPO) recovery data was upward over the past
10 years. When comparing the most recent 3 years
of data, 24 OPOs (41%) had two consecutive years
of growth. Deceased donation in 2004 increased 11%
over 2003, (7152 donors up from 6457). Compared
with 1995, organ donation in 2004 increased by 33%.
Increased organ donation was noted for all organs, with
the exception of the heart.
(iii) Between 1995 and 2004, the number of donors pro-
viding organs after cardiac death increased more than
6-fold, from 64 to 391, a much steeper rate of increase
than for donors providing organs after brain death. Al-
though donation after cardiac death (DCD) makes up
a relatively small fraction of the national percentage
of deceased donors (5% in 2004), the full potential for
DCD to expand the national deceased organ donor pool
is reflected by the fact that only seven DSAs accounted
for 58% of all instances of DCD, and, in these DSAs,
DCD accounted for 17–20% of their donors.
(iv) Increased public awareness of the organ donor short-
age is demonstrated by the year-to-year increase in the
number of organs donated by living donors between
1995 and 2004. Over the past 10 years, the number of
donated organs increased from 3493 to 7002. In fact,
from 2001 to 2003, the number of living organ donors
surpassed the number of deceased donors.
Immunosuppression
This article presents an organ-by-organ review of immuno-
suppression use over the last 10 years. New to this year’s
report is a wealth of data on immunosuppressive regimens
that include more than one drug; in previous years, use of
drugs was reported only individually.
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In response to the concerns about the adverse effects as-
sociated with steroid-based regimens, many transplant re-
cipients are being taken off corticosteroids as a mainte-
nance therapy (steroid withdrawal) or not being given it in
the first place (steroid avoidance). Tables and figures new
to this year’s report provide useful windows on this impor-
tant changing trend. Highlights of the article follow:
(i) Antibody-based induction therapy continues to be
used for the majority of kidney and pancreas recipi-
ents, including pancreas after kidney and simultane-
ous pancreas-kidney transplant recipients (72–81% in
2004); it was used for approximately half of all intes-
tine, heart and lung recipients and remains uncommon
for liver recipients (21% in 2004).
(ii) For recipients of most organs, the use of calcineurin
inhibitors as maintenance therapy at the time of dis-
charge was characterized by a clear transition from cy-
closporine to tacrolimus.
(iii) Corticosteroids were still administered to the majority
of patients, though regimens of steroid avoidance and
steroid withdrawal have been increasing in use.
(iv) The percentage of patients treated for acute rejection
during the first year following transplantation has con-
tinued to fall.
Pediatric transplantation
This article provides a comprehensive review of trends in
pediatric donation over the past 10 years. Pediatric pa-
tients, those 17 years and younger, have characteristics
specific to their age, among them distinct etiologies of or-
gan failure, complexity of surgical procedures and differing
pharmacokinetic disposition of immunosuppressants. The
article investigates waiting list characteristics and trans-
plantation and survival outcomes by organ for this age
group. In total, there were 2269 pediatric organ transplant
candidates at the end of 2004, reversing a 3-year trend
of decreases. The article concludes with a review of re-
cent updates in organ allocation policy and raises further
research challenges. Some specific highlights from the ar-
ticle include the following:
(i) In 2004, there were more candidates in all age groups
except 1- to 5-year-old children. Candidates younger
than 11 years of age continue to account for just over
half of pediatric candidates. However, the increase in
candidates in 2004 did not reverse the ongoing decline
of pediatric candidates as a percentage of all candi-
dates; children currently account for 3% of all trans-
plant candidates.
(ii) Current 3-year graft and patient survival for pedi-
atric recipients is comparable to adult survival for all
but intestine (where interpretation is limited by small
numbers of recipients).
(iii) During the past decade, the graft survival rate of
kidneys transplanted into pediatric recipients has im-
proved, especially for young recipients aged less than
11 years. Adolescent recipients have not manifested
similar superior graft survival rates.
(iv) The policy of allocating kidneys to pediatric candidates
was revised so that kidneys from donors less than 35
years old are now offered preferentially to pediatric
candidates. The new pediatric preference algorithm for
liver shares pediatric donor livers regionally to pediatric
candidates based on a model for end-stage liver dis-
ease/pediatric end-stage liver disease (MELD/PELD)
score rather than on a waiting list mortality risk. Pe-
diatric donor lungs are now offered preferentially to
pediatric candidates before being offered to adult can-
didates.
Kidney and pancreas transplantation
This article reviews kidney and pancreas transplantation
data for 2004 and the past decade, following trends in kid-
ney alone, simultaneous kidney-pancreas, pancreas after
kidney and isolated pancreas transplantation. Data on kid-
ney recipient characteristics and transplant outcomes are
extensively reviewed, including differences in patient and
graft survival rates between recipients of expanded crite-
ria donor (ECD) non-ECD and living donor kidneys. Charac-
teristics of wait-listed registrants’ time spent on the wait-
ing list are discussed. A special section on DCD presents
data on the risk of delayed graft function and survival rates
following transplantation of DCD kidneys. The section on
pancreas transplantation includes a discussion of pancreas
utilization. The article also covers recent changes in poli-
cies covering kidney-pancreas allocation. Highlights of the
article include the following:
(i) The number of patients waiting for deceased donor
kidney transplants continues its relentless increase.
At the end of 2004, there were 57 910 patients on the
waiting list. There were 27 131 new kidney waiting list
registrations in 2004, an increase of 11% since 2003
and 52% since 1995.
(ii) The overall number of donors continues to increase.
The total number of kidneys transplanted increased by
6% between 2003 and 2004, from 14 856 to 15 671,
after an average annual increase of approximately 4%
since 1995.
(iii) Deceased donor kidney transplants increased by 8%
between 2003 and 2004, by far the largest increase in
the decade, while living donor transplants increased
only 3%. This represents a reversal of previous
trends, but the number of living kidney donors con-
tinues to exceed the number of deceased donors.
(iv) African Americans made up 35% of the active kidney
waiting list at the end of 2004, while whites made
up 39%. While the percentage of African Americans
active on the waiting list has remained stable over the
past decade, the percentage of whites has decreased
by about 10% as a representation of Hispanics and
Asians has increased. The age group with the greatest
percentage increase in registrations since 2003 was
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the group aged 65 years and older (20%), followed by
the 50- to 64-year-old age group (15%).
(v) Donation after cardiac death has increased steadily
since 2000. Although the absolute numbers remain
small, kidneys transplanted from DCD donors in-
creased by 39% between 2003 and 2004.
(vi) One-year patient survival ranged from 91% for de-
ceased donor ECD kidney recipients to 98% for pa-
tients receiving kidneys from living donors. By 5 years
after transplantation, recipient survival is 20% lower
among recipients of deceased donor ECD kidneys
(70%) than among living donor kidneys (90%) and
15% less than among deceased donor non-ECD kid-
ney recipients (85%).
(vii) The number of people living with a functioning kidney
transplant doubled from 1995 to 2004. Health care
providers in all settings are increasingly likely to be
exposed to these organ transplant recipients.
(viii) Patient survival following simultaneous pancreas-
kidney (SPK) transplantation is excellent and has in-
creased incrementally since 1995. Death rates for re-
cipients in the first year following transplant have de-
creased, from 60 per 1000 patient-years at risk in 2001
to 45 in 2003.
(ix) The number of solitary pancreas transplants increased
dramatically in 2004, with 419 pancreas after kidney
(PAK) and 185 pancreas transplant alone (PTA) trans-
plants performed. This is an 18% increase in pancreas
utilization for PAK and a 14% increase in PTA since
2003.
Liver and intestine transplantation
This article reviews liver and intestine transplantation, us-
ing the last decade’s worth of data. The article covers liver
waiting list characteristics, transplant recipient character-
istics, patient and graft survival and posttransplant death
rates. The increasing prominence of hepatitis C as an indi-
cation for transplantation is also highlighted. Special atten-
tion is given to the impact of MELD and PELD throughout
the liver section, as there are now 3 years of survival data
since the implementation of the system. In the intestine
section, similar areas are discussed. Highlights of the arti-
cle include:
(i) The increased utilization of deceased donor livers and
a resurgence in living-donor transplants has enabled
the number of liver transplants performed yearly to
surpass 5500.
(ii) Although waiting time for all patients on the liver wait-
ing list has not declined, pretransplant death rates
have.
(iii) In general, the 1-year posttransplant death rate in-
creased with an increasing MELD score. In the pe-
diatric population, a similar trend was observed for
higher PELD scores, but since the number of trans-
plants performed in the pediatric population with PELD
values above 30 is limited, death rates for this group
could not be calculated.
(iv) Utilizing livers from donors over 50 years of age is
associated with a significant decline in long-term sur-
vival.
(v) Long-term survival following liver transplantation ap-
pears to be reduced in patients with chronic hepatitis
C virus.
(vi) The number of patients who received a small intestine
transplant has gradually increased over the past 10
years from 46 in 1995 to 152 in 2004.
(vii) Posttransplant intestine graft survival has increased
stepwise since 2000 and patient survival at 1 year now
exceeds 80% for the first time.
Thoracic transplantation
This article describes the current state of heart, lung and
heart-lung transplantation and examines trends over the
past decade. Although the number of thoracic organ trans-
plants performed has declined in recent years, transplan-
tation remains an important treatment option for selected
patients with a failing heart, failing lungs or both. The article
covers waiting list characteristics, death rates of patients
on the waiting list, characteristics of transplant recipients
and posttransplant outcomes for heart, lung and combined
transplants. A few highlights of the article include:
(i) The number of heart transplants per million population
continued to decrease over the past decade (from 8.99
procedures per million population in 1995 to 6.87 pro-
cedures per million population in 2004). The most no-
table decline was among those ages from 50 to 64—
from 35.86 transplants per million population in 1995
to 19.12 transplants per million population in 2004.
(ii) The total number of patients active on the heart wait-
ing list continued to decline during the period. This is
primarily a reflection of the decline in the percentage
of transplant candidates with a coronary artery disease
classification.
(iii) The status of patients on the heart waiting list at the
end of each calendar year has changed significantly
since the creation of waiting list Status 1A and Status
1B. The percentage of Status 2 patients declined from
84% in 1997 to 72% in 2004. At the same time, the
percentage of Status 1B patients steadily increased,
from 14% in 1999 to 21% in 2004.
(iv) Both the number and the rate of deaths of patients on
the heart waiting list have declined significantly since
1995. Annual death rates per 1000 patient-years at risk
declined from 259 in 1995 to 156 in 2004.
(v) The waiting time for new lung waiting list registrants
decreased significantly among registrants aged 11
years and older between 1999 and 2004.
(vi) For the sixth consecutive year, the number of patients
on the active waiting list for a heart-lung transplant
continued to decrease. From a high of 179 patients in
1998, the total number of active patients decreased to
83 in 2004. There were only 39 combined heart-lung
transplants performed in 2004, a decline from a high
of 69 in 1995 and an increase from a low of 27 in 2001.
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(vii) Reported unadjusted patient survival rates at
3 months, 1 year, 3 years and 5 years for heart-
lung recipients were 70%, 58%, 52% and 40%,
respectively—lower than those for heart or lung
recipients alone.
Center-specific reporting
This article describes the purpose and methods of center-
specific reporting by focusing on how to interpret anal-
yses of a particular set of posttransplant outcomes for
transplant center-specific reports, though the methods
and concerns discussed are applicable to other analy-
ses presented in the reports for both transplant centers
and OPOs. Reporting the results obtained from transplant
centers and OPOs is one of the many contract respon-
sibilities of the SRTR. These analyses are used for dif-
ferent purposes by patients and families, by transplant
professionals, by insurance companies and other payers
and by regulatory bodies both within and outside of the
OPTN.
The technical issues discussed the focus on the concept
of ‘expected survival’, which addresses the critical ques-
tion, ‘What rate is expected for the patients at this center, if
they had outcomes comparable to the national experience
for similar patients?’ In addition to an overall discussion of
the analytical methods used to address this question, we
also examine the technical details of how to ensure that
graft and patient survival are risk-adjusted for the donor
and recipient characteristics of the particular center by in-
cluding the right variables for modeling, how to aggregate
observed and expected events at that center, and different
methods for calculating loss to follow-up.
The article concludes with a detailed description of the
screening process for transplant centers—the statistical
and clinical criteria used, and the procedures followed by
the OPTN Membership and Professional Standards Com-
mittee when a center is flagged for review.
Special focus article: lung allocation
In May 2005, the OPTN changed the lung allocation policy
from a system based exclusively on waiting time to one
that includes estimates of survival probability. The new
Lung Allocation Score incorporates and compares candi-
dates’ estimated survival rate for remaining on the waiting
list and for receiving a transplant. A key component of the
new system is a candidate’s expected 1-year transplant
benefit, calculated by subtracting a waiting list urgency
measure from a posttransplant survival measure.
A great deal of clinical, statistical and ethical consideration
went into the development of this new system, as detailed
in this article. Highlights include the following:
(i) A historical overview of lung allocation and lung allo-
cation policy, particularly the actions of the OPTN Tho-
racic Organ Transplantation Committee and Lung Allo-
cation Subcommittee.
(ii) Discussion of the ethical issues involved in developing
the new system, including the effort to balance justice
with utility.
(iii) Detailed explanations of how the new allocation algo-
rithm was developed, including the decisions made
in diagnosis grouping, determining how to incorpo-
rate measures of waiting list urgency and transplant
benefit, the use of the Thoracic Simulated Alloca-
tion Model and special rules governing the alloca-
tion of organs from pediatric donors and to pediatric
candidates.
(iv) It is expected and hoped that this important change
in policy will both reduce the number of deaths on
the lung waiting list and minimize the number of fu-
tile transplants.
Analytical methods and database design
This article is a combination of two articles that were pub-
lished separately in previous reports, covering the database
and analytical issues faced by the SRTR. The first section
of the article focuses mainly on issues in transplant data
sources and data collection. A brief summary of the scope
of data available is given, along with discussion on the im-
provements of data submission patterns both on the wait-
ing list and after transplant, as well as their implications for
analysis. As in previous years, we discuss the value that
the various extra ascertainment sources which the SRTR
uses gives the data.
The second half of this article centers on methods of
analysis using these data for transplant research. Essen-
tial analytical approaches used by the SRTR are reviewed,
with special attention placed on unadjusted and covariate-
adjusted analyses.
The article concludes with a description of Simulated Al-
location Modeling and its importance for comparing out-
comes based on current versus proposed national alloca-
tion policies.
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